FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest drug approvals
- Merilog (insulin aspart-szjj) - February 14, 2025
- Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) - February 14, 2025
- Romvimza (vimseltinib) - February 14, 2025
- Vimkunya (chikungunya vaccine, recombinant) - February 14, 2025
- Ospomyv (denosumab-dssb) - February 13, 2025
- Xbryk (denosumab-dssb) - February 13, 2025
- Gomekli (mirdametinib) - February 11, 2025
- Emblaveo (avibactam and aztreonam) - February 07, 2025
- Onapgo (apomorphine hydrochloride) - February 03, 2025
- Journavx (suzetrigine) - January 30, 2025
- Symbravo (meloxicam and rizatriptan) - January 30, 2025
- Avtozma (tocilizumab-anoh) - January 24, 2025
- Grafapex (treosulfan) - January 21, 2025
- Datroway (datopotamab deruxtecan-dlnk) - January 17, 2025
- Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) - December 27, 2024
- Alhemo (concizumab-mtci) - December 20, 2024
- Alyftrek (deutivacaftor, tezacaftor and vanzacaftor) - December 20, 2024
- Symvess (acellular tissue engineered vessel-tyod) - December 19, 2024
- Tryngolza (olezarsen) - December 19, 2024
- Ensacove (ensartinib) - December 18, 2024